Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study

By Paglino Chiara   Imarisio Ilaria   Ganini Carlo   Morbini Patrizia   Vercelli Alessandro   Bregant Cristina   Porta Camillo  

Future Oncology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1605-1612

Future Medicine

Access to resources Recommend Favorite

Comparison of Survival Rates in Patients with Metastatic Renal Cell Carcinoma According to Treatment Era Including Cytokine and Targeted Therapy

By Takagi Toshio   Kondo Tsunenori   Kennoki Takafumi   Iizuka Jyunpei   Kobayashi Hirohito   Hashimoto Yasunobu   Tanabe Kazunari  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 439-443

Oxford University Press

Access to resources Recommend Favorite

Surgical Resection of Metastatic Renal Cell Carcinoma: The University of Iowa Experience

By Dreicer R.   Galbraith S.S.   Davis C.S.   See W.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 3, 1997-05 ,pp. : 99-101

Elsevier

Access to resources Recommend Favorite

Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma

By Tai Cheng-Jeng  

Acta Oncologica, Vol. 48, Iss. 6, 2009-08 ,pp. : 931-932

Informa Healthcare

Access to resources Recommend Favorite

Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy

By Jessen Christian   Agerbaek Mads   Maase Hans Von Der  

Acta Oncologica, Vol. 48, Iss. 3, 2009-04 ,pp. : 411-417

Informa Healthcare

Access to resources Recommend Favorite